Selected patents
Auer M, Koszela J, Tyers M (2014). UPS-CONA On-bead ubiquitination assay: A high-throughput enzymatic on-bead assay for interrogation of the ubiquitin-proteasome system in vitro by confocal nanoscanning. European Patent Application, Application Number: P213818GB, Sep 04, 2014; PCT filed Sep 04, 2015, published, Mar 10, 2016, WO 2016/034895 A1.
Auer M, Koszela J, Tyers M (2014). UPS-CONA On-bead ubiquitination assay: A high-throughput enzymatic on-bead assay for interrogation of the ubiquitin-proteasome system in vitro by confocal nanoscanning. European Patent Application, Application Number: P213818GB, Sep 04, 2014; PCT filed Sep 04, 2015, published, Mar 10, 2016, WO 2016/034895 A1.
Auer M, Mudd G (2014). Novel Synthetic Route to Functionalized single Isomer Rhodamine dyes European Patent Application, Application Number: 1413685.7, Aug 01, 2014.
Auer M, Mudd G (2014). Novel Synthetic Route to Functionalized single Isomer Rhodamine dyes European Patent Application, Application Number: 1413685.7, Aug 01, 2014.
Auer M, Mole D, Webster S, Wilson K (2013). Novel Screening Method (Intracellular Affinity Selection Screening Method: TAPS), European Patent Application, Application Number: 1321410.1, Dec 04. International patent application filed under PCT on 5th December 2014, International Patent Application No PCT/GB2014/053572, published Jun 11, 2015, WO 2016/082900 A1.
Auer M, Mole D, Webster S, Wilson K (2013). Novel Screening Method (Intracellular Affinity Selection Screening Method: TAPS), European Patent Application, Application Number: 1321410.1, Dec 04. International patent application filed under PCT on 5th December 2014, International Patent Application No PCT/GB2014/053572, published Jun 11, 2015, WO 2016/082900 A1.
Auer M, Gstach H, Roth G, Wiesmueller KH (2008, 2009). Method for manufacturing and application of random ordered arrays of chemical compounds. PCT/EP2008/068,056, WO Patent WO/2009/080,766.
Auer M, Gstach H, Roth G, Wiesmueller KH (2008, 2009). Method for manufacturing and application of random ordered arrays of chemical compounds. PCT/EP2008/068,056, WO Patent WO/2009/080,766.
Auer M. Hintersteiner M, Kimmerlin (2008) Post-screening labeling of on-bead compounds. PCT/EP2008/057,878, WO/2008/145,609 , WO Patent WO/2009/000,775.
Auer M. Hintersteiner M, Kimmerlin (2008) Post-screening labeling of on-bead compounds. PCT/EP2008/057,878, WO/2008/145,609 , WO Patent WO/2009/000,775.
Auer M, Meisner N, Uhl V (2003, 2005, 2008). Method for the identification of inhibitors of the binding of ARE-containing mRNA and a HuR protein. US Patent 7,399,583; EP Patent 1,497,327; WO Patent 2,003,087,815; PCT/EP2003/004,008 ; EP Patent App. 20,030,746,306; US Patent App. 20,060/008,802.
Auer M, Meisner N, Uhl V (2003, 2005, 2008). Method for the identification of inhibitors of the binding of ARE-containing mRNA and a HuR protein. US Patent 7,399,583; EP Patent 1,497,327; WO Patent 2,003,087,815; PCT/EP2003/004,008 ; EP Patent App. 20,030,746,306; US Patent App. 20,060/008,802.
Auer M. Hintersteiner M, Kimmerlin T (2008). Method of making covalent conjugates with his-tagged proteins. WO Patent App. PCT/EP2008/056,361.
Auer M. Hintersteiner M, Kimmerlin T (2008). Method of making covalent conjugates with his-tagged proteins. WO Patent App. PCT/EP2008/056,361.
Auer M, Meisner NC, Hintersteiner M, Schindler T, Gstach H, (2007). Method for the screening of compounds that modulate the interaction between mRNA and proteins and compounds obtainable thereby, EP Patent 1,859,278, WO/2006/094,688.
Auer M, Meisner NC, Hintersteiner M, Schindler T, Gstach H, (2007). Method for the screening of compounds that modulate the interaction between mRNA and proteins and compounds obtainable thereby, EP Patent 1,859,278, WO/2006/094,688.
M Auer, Hackermüller J, Jaritz M, Meisner NC (2006). Screening Assays, EP Patent 1,713,913.
M Auer, Hackermüller J, Jaritz M, Meisner NC (2006). Screening Assays, EP Patent 1,713,913.
Auer M, Gstach H (2001, 2005). Fluorescent dyes (AIDA) for solid phase and solution phase screening. US Patent App. 11/139,753, EP Patent 1,140,856, US Patent App. 09/754,958, US Patent App. 20,010/005,752, US Patent 6,207,831, WO Patent WO/2000/037,448.
Auer M, Gstach H (2001, 2005). Fluorescent dyes (AIDA) for solid phase and solution phase screening. US Patent App. 11/139,753, EP Patent 1,140,856, US Patent App. 09/754,958, US Patent App. 20,010/005,752, US Patent 6,207,831, WO Patent WO/2000/037,448.
M Auer, Hackermüller J, Jaritz M, Meisner NC (2004, 2005). A method for dissecting the RNA secondary structure dependence of RNA-ligand interactions. WO Patent App. PCT/EP2004/004,909, WO Patent WO/2004/099,411, EP Patent App. 20,050,701,358.
M Auer, Hackermüller J, Jaritz M, Meisner NC (2004, 2005). A method for dissecting the RNA secondary structure dependence of RNA-ligand interactions. WO Patent App. PCT/EP2004/004,909, WO Patent WO/2004/099,411, EP Patent App. 20,050,701,358.
Auer M, Jung T (2003, 2004). Screening method involving transfected primary cells. WO Patent WO/2004/029,620; PCT/EP2003/010,681; US Patent App. 10/526,284; US Patent App. 20,060/040,249.
Auer M, Jung T (2003, 2004). Screening method involving transfected primary cells. WO Patent WO/2004/029,620; PCT/EP2003/010,681; US Patent App. 10/526,284; US Patent App. 20,060/040,249.
Auer M, Hammerschmid F, Stingl G (2003). Elisa testsystem zur Bestimmung von Substanzen, die die Bindung zwischen IgE und dessen Receptor inhibiert. DE Patent 69,626,860.
Auer M, Hammerschmid F, Stingl G (2003). Elisa testsystem zur Bestimmung von Substanzen, die die Bindung zwischen IgE und dessen Receptor inhibiert. DE Patent 69,626,860.
M Auer, N Meisner, Seifert JM (2003). Labeling methodology comprising oligopeptides. WO Patent App. PCT/EP2003/013,715; US Patent App. 20,060/134,691; US Patent App. 10/534,966.
M Auer, N Meisner, Seifert JM (2003). Labeling methodology comprising oligopeptides. WO Patent App. PCT/EP2003/013,715; US Patent App. 20,060/134,691; US Patent App. 10/534,966.
Auer M, Hammerschmid F, Stingl G (2002). Elisa testsystem for detecting substances interfering with the binding between IgE and its receptor. EP Patent 0,882,229.
Auer M, Hammerschmid F, Stingl G (2002). Elisa testsystem for detecting substances interfering with the binding between IgE and its receptor. EP Patent 0,882,229.
Auer M, Gautel M, Goody R, Greulich KO, Labeit S, Seidel C, Wolfrum J. (1988). Verfahren zur optischen Charakterisierung von Nukleinsäuren und Oligonukleotiden. DE Patent 3,807,975.
Auer M, Gautel M, Goody R, Greulich KO, Labeit S, Seidel C, Wolfrum J. (1988). Verfahren zur optischen Charakterisierung von Nukleinsäuren und Oligonukleotiden. DE Patent 3,807,975.
Auer M, Hammerschmid F, Stingl G (2001). Elisa screening method for inhibitors of human IgE binding to the high affinity receptor, Fc epsilon RI alpha. US Patent 6,258,549.
Auer M, Hammerschmid F, Stingl G (2001). Elisa screening method for inhibitors of human IgE binding to the high affinity receptor, Fc epsilon RI alpha. US Patent 6,258,549.
Greulich KO, Seidel C, Wolfrum J, Auer M, Gautel M, Goody R, Labeit M (2000). Optical characterization of nucleic acids and oligonucleotides. WO Patent WO/2000/037,448.
Greulich KO, Seidel C, Wolfrum J, Auer M, Gautel M, Goody R, Labeit M (2000). Optical characterization of nucleic acids and oligonucleotides. WO Patent WO/2000/037,448.
Auer M, Hammerschmid F, Stingl G (1997). Elisa Test System. WO Patent 1,997,024,617.
Auer M, Hammerschmid F, Stingl G (1997). Elisa Test System. WO Patent 1,997,024,617.